SEC Form 4 · accession 0001161697-19-000053
KORU Medical Systems, Inc. · KRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen Fisher
Officer — Chief Financial Officer
Period of report
Jan 29, 2019
Accepted (ET)
Feb 4, 2019 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000704440
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase Common StockF1 | $1.57 | Jan 29, 2019 | A | 500,000 | A | — | Jan 29, 2029 | Common Stock | 500,000 | 1,000,000 | D |
Explanation of responses
- F1Incentive stock options granted pursuant to the Repro Med Systems, Inc. 2015 Stock Option Plan, as amended. Options vest in increments of 100,000 on the first anniversary of the date of grant and each anniversary thereafter until fully vested.
Remarks
The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.